The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

NCT05836987 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

5350

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DEVICE: AFSW Guided DOAC
DRUG: Continuous DOAC therapy

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]